Clinical Trial

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)

– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical…

1 year ago

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

FDA approval for the IND submission to conduct its trial already secured Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Celly Nutrition Launches unbuzzd(TM) Post-Alcohol Consumption Recovery Supplement in 18 Packs on Amazon

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company")") announces the release…

1 year ago

Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024

Financial HighlightsDirect MagnetOsTM sales rose by 149% to CHF 50.6 million in the first nine months of 2024, from CHF…

1 year ago

Cantargia’s Strong Phase 2 Clinical Data in Pancreatic Cancer with Nadunolimab Published in Clinical Cancer Research

LUND, SWEDEN / ACCESSWIRE / October 10, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the…

1 year ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation…

1 year ago

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization…

1 year ago

Every Cure Receives Five-Year, $60 Million Commitment Through TED’s Audacious Project to Repurpose Medications for Global Impact

PHILADELPHIA, Oct. 9, 2024 /PRNewswire/ -- Every Cure, an AI-powered nonprofit biotech organization, has received a five-year $60 million commitment through…

1 year ago

ProofPilot Welcomes Roslyn Schneider to Advisory Board

NEW YORK, Oct. 9, 2024 /PRNewswire/ -- ProofPilot, the industry's first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and…

1 year ago

Springbok Analytics Receives FDA 510(k) Clearance For MuscleView™, its AI Muscle Health Analysis From a Rapid MRI Scan

Springbok Analytics is at the forefront of muscle health—powering elite athletes, driving muscle-related research and clinical trials, and empowering individuals…

1 year ago